TY - JOUR
T1 - Synthesis and evaluation of oligonucleotides incorporating novel artificial nucleobases for the selective formation of non-natural type triplexes.
AU - Nakashima, S.
AU - Matsuura, N.
AU - Nagatsugi, F.
AU - Maeda, M.
AU - Sasaki, Shigeki
PY - 1997/1/1
Y1 - 1997/1/1
N2 - Regulation of specific gene expression by the sequence specific triplex formation has been expected as a new biological tool or a new therapeutic method in the so-called antigene strategy. As native nucleobases form triplexes only within homopurine-homopyrimidine duplexes, expansion of the target sequences to general ones has been desired. We have previously reported the selective formation of base triplets by the non-native nucleobases (1, 2) with a CG or a TA base pair, respectively, in the organic solvent. In this paper, we wish to report the synthesis of the new non-native bases (3, 4, 9-11) and their incorporation into the triplex-forming oligonucleotides (TFOs), as well as their ability of triplex formation.
AB - Regulation of specific gene expression by the sequence specific triplex formation has been expected as a new biological tool or a new therapeutic method in the so-called antigene strategy. As native nucleobases form triplexes only within homopurine-homopyrimidine duplexes, expansion of the target sequences to general ones has been desired. We have previously reported the selective formation of base triplets by the non-native nucleobases (1, 2) with a CG or a TA base pair, respectively, in the organic solvent. In this paper, we wish to report the synthesis of the new non-native bases (3, 4, 9-11) and their incorporation into the triplex-forming oligonucleotides (TFOs), as well as their ability of triplex formation.
UR - http://www.scopus.com/inward/record.url?scp=0031324889&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031324889&partnerID=8YFLogxK
M3 - Article
C2 - 9585985
AN - SCOPUS:0031324889
SN - 0261-3166
SP - 33
EP - 34
JO - Nucleic acids symposium series
JF - Nucleic acids symposium series
IS - 37
ER -